Leeward Investments LLC MA Buys 21,997 Shares of Cabot Corporation $CBT

Leeward Investments LLC MA boosted its stake in shares of Cabot Corporation (NYSE:CBT) by 12.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 203,616 shares of the specialty chemicals company’s stock after acquiring an additional 21,997 shares during the quarter. Leeward Investments LLC MA’s holdings in Cabot were worth $15,271,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CBT. GAMMA Investing LLC grew its holdings in Cabot by 26.1% during the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock worth $141,000 after acquiring an additional 352 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Cabot by 9.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,850 shares of the specialty chemicals company’s stock worth $819,000 after acquiring an additional 819 shares during the last quarter. Janney Montgomery Scott LLC bought a new position in shares of Cabot in the 1st quarter valued at about $975,000. Copeland Capital Management LLC boosted its stake in shares of Cabot by 5.8% in the 1st quarter. Copeland Capital Management LLC now owns 805,504 shares of the specialty chemicals company’s stock valued at $66,970,000 after purchasing an additional 44,132 shares during the last quarter. Finally, KBC Group NV boosted its stake in shares of Cabot by 31.5% in the 1st quarter. KBC Group NV now owns 2,690 shares of the specialty chemicals company’s stock valued at $224,000 after purchasing an additional 644 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of CBT stock opened at $71.31 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The company has a market capitalization of $3.79 billion, a P/E ratio of 9.32 and a beta of 0.88. The company’s 50 day moving average price is $76.52 and its two-hundred day moving average price is $76.48. Cabot Corporation has a 52 week low of $66.50 and a 52 week high of $117.46.

Cabot (NYSE:CBT) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. The firm had revenue of $923.00 million for the quarter, compared to the consensus estimate of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, analysts expect that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 3.03% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CBT. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Friday. Mizuho cut their price target on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research report on Friday, October 3rd. Finally, UBS Group set a $82.00 price target on shares of Cabot and gave the company a “neutral” rating in a research report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $85.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.